ZGZhenyu Gong

Zhenyu Gong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhenyu Gong has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Addressing benchmarking gaps in large language models for health and medicine with dynamic red-teaming

    by Jiazhen Pan, Bailiang Jian, Paul Hager, Yundi Zhang, Che Liu, Friedrike Jungmann, Hongwei Bran Li, Julian Canisius, Chenyu You, Junde Wu, et al.

    Large language models (LLMs) are increasingly used to answer health-related questions and support healthcare workflows, yet evidence for their safety still relies heavily on static benchmarks that can rapidly become obsolete or be optimized against. Here we introduce a Dynamic, Automatic and Systematic (DAS) red-teaming audit framework that continuously stress-tests LLMs for health across four safety-critical axes: robustness, privacy, bias and hallucination. Validated against board-certified clinicians, a suite of adversarial agents autonomously mutates health-related test cases to uncover vulnerabilities in real time. Applying DAS to 15 state-of-the-art LLMs revealed a profound gap between high static benchmark performance and low dynamic reliability—the ‘benchmarking gap’. Despite median MedQA accuracy exceeding 80%, 94% of previously correct answers failed under dynamic robustness testing. This brittleness generalized to the realistic, open-ended HealthBench dataset, where top-tier models exhibited failure rates exceeding 70%, suggesting that high scores on established static benchmarks may reflect superficial memorization. We observed similarly high failure rates across other domains: privacy leaks were elicited in 86% of scenarios, cognitive bias priming altered recommendations in 81% of fairness tests and hallucination rates exceeded 74% in widely used models. By converting LLM safety evaluation for health from a static checklist into a living adversarial audit, DAS provides a scalable framework for surfacing latent risks before such systems are deployed in consumer-facing health assistants and broader clinical workflows.


  • Challenges and material innovations in drug delivery to central nervous system tumors

    by Zhenyu Gong, Dairan Zhou, Dejun Wu, Yaguang Han, Hao Yu, Haotian Shen, Wei Feng, Lijun Hou, Yu Chen, Tao Xu


  • Open Access

    A Multi-Center, Multi-Parametric MRI Dataset of Primary and Secondary Brain Tumors

    by Zhenyu Gong, Tao Xu, Nan Peng, Xing Cheng, Chen Niu, Benedikt Wiestler, Fan Hong, Hongwei Bran Li

    Brain metastases (BMs) and high-grade gliomas (HGGs) are the most common and aggressive types of malignant brain tumors in adults, with often poor prognosis and short survival. As their clinical symptoms and image appearances on conventional magnetic resonance imaging (MRI) can be astonishingly similar, their accurate differentiation based solely on clinical and radiological information can be very challenging, particularly for “cancer of unknown primary”, where no systemic malignancy is known or found. Non-invasive multiparametric MRI and radiomics offer the potential to identify these distinct biological properties, aiding in the characterization and differentiation of HGGs and BMs. However, there is a scarcity of publicly available multi-origin brain tumor imaging data for tumor characterization. In this paper, we introduce a multi-center, multi-origin brain tumor MRI (MOTUM) imaging dataset obtained from 67 patients: 29 with high-grade gliomas, 20 with lung metastases, 10 with breast metastases, 2 with gastric metastasis, 4 with ovarian metastasis, and 2 with melanoma metastasis. This dataset includes anonymized DICOM files alongside processed FLAIR, T1-weighted, contrast-enhanced T1-weighted, T2-weighted sequences images, segmentation masks of two tumor regions, and clinical data. Our data-sharing initiative is to support the benchmarking of automated tumor segmentation, multi-modal machine learning, and disease differentiation of multi-origin brain tumors in a multi-center setting.


  • Open Access

    Universal Urban Spreading Pattern of COVID-19 and Its Underlying Mechanism

    by Yongtao Zhang, Hongshen Zhang, Mincheng Wu, Shibo He, Yi Fang, Yanggang Cheng, Zhiguo Shi, Cunqi Shao, Chao Li, Songmin Ying, et al.

    Currently, the global situation of COVID-19 is aggravating, pressingly calling for efficient control and prevention measures. Understanding spreading pattern of COVID-19 has been widely recognized as a vital step for implementing non-pharmaceutical measures. Previous studies investigated such an issue in large-scale (e.g., inter-country or inter-state) scenarios while urban spreading pattern still remains an open issue. Here, we fill this gap by leveraging the trajectory data of 197,808 smartphone users (including 17,808 anonymous confirmed cases) in 9 cities in China. We find a universal spreading pattern in all cities: the spatial distribution of confirmed cases follows a power-law-like model and the spreading centroid is time-invariant. Moreover, we reveal that human mobility in a city drives the spatialtemporal spreading process: long average travelling distance results in a high growth rate of spreading radius and wide spatial diffusion of confirmed cases. With such insight, we adopt Kendall model to simulate urban spreading of COVID-19 that can well fit the real spreading process. Our results unveil the underlying mechanism behind the spatial-temporal urban evolution of COVID-19, and can be used to evaluate the performance of mobility restriction policies implemented by many governments and to estimate the evolving spreading situation of COVID-19.

  • Open Access

    An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma

    by Zhenyu Gong, Fan Hong, Hongxiang Wang, Xu Zhang, Juxiang Chen

    Background: The prognosis of the glioblastoma (GBM) is dismal. This study aims to select an optimal RNA signature for prognostic prediction of GBM patients. Methods: For the training set, the long non-coding RNA (lncRNA) and mRNA expression profiles of 151 patients were downloaded from the TCGA. Differentially expressed mRNAs (DEGs) and lncRNAs (DE-lncRNAs) were identified between good prognosis and bad prognosis patients. Optimal prognostic mRNAs and lncRNAs were selected respectively, by using univariate Cox proportional-hazards (PH) regression model and LASSO Cox-PH model. Subsequently, four prognostic scoring models were built based on expression levels or expression status of the selected prognostic lncRNAs or mRNAs, separately. Each prognostic model was applied to the training set and an independent validation set. Function analysis was used to uncover the biological roles of these prognostic DEGs between different risk groups classified by the mRNA-based signature. Results: We obtained 261 DEGs and 33 DE-lncRNAs between good prognosis and bad prognosis patients. A panel of eight mRNAs and a combination of ten lncRNAs were determined as predictive RNAs by LASSO Cox-PH model. Among the four prognostic scoring models using the eight-mRNA signature or the ten-lncRNA signature, the one based on the expression levels of the eight mRNAs showed the greatest predictive power. The DEGs between different risk groups using the eight prognostic mRNAs were functionally involved in calcium signaling pathway, neuroactive ligand-receptor interaction pathway, and Wnt signaling pathway. Conclusion: The eight-mRNA signature has greater prognostic value than the ten-lncRNA-based signature for GBM patients based on bioinformatics analysis.